Equipoise in the Enhanced Supression of the Platelet IIb/IIIa Receptor with Integrilin Trial (ESPRIT): A critical appraisal. Comment
Publication
, Journal Article
Tcheng, J; Mann, H; London, AJ; Mann, J
Published in: Clinical Trials
July 13, 2005
Duke Scholars
Published In
Clinical Trials
ISSN
1740-7745
Publication Date
July 13, 2005
Volume
2
Issue
3
Start / End Page
242 / 243
Related Subject Headings
- Statistics & Probability
- 5203 Clinical and health psychology
- 4905 Statistics
- 3202 Clinical sciences
- 1103 Clinical Sciences
- 0104 Statistics
Citation
APA
Chicago
ICMJE
MLA
NLM
Tcheng, J., Mann, H., London, A. J., & Mann, J. (2005). Equipoise in the Enhanced Supression of the Platelet IIb/IIIa Receptor with Integrilin Trial (ESPRIT): A critical appraisal. Comment. Clinical Trials, 2(3), 242–243.
Tcheng, J., H. Mann, A. J. London, and J. Mann. “Equipoise in the Enhanced Supression of the Platelet IIb/IIIa Receptor with Integrilin Trial (ESPRIT): A critical appraisal. Comment.” Clinical Trials 2, no. 3 (July 13, 2005): 242–43.
Tcheng J, Mann H, London AJ, Mann J. Equipoise in the Enhanced Supression of the Platelet IIb/IIIa Receptor with Integrilin Trial (ESPRIT): A critical appraisal. Comment. Clinical Trials. 2005 Jul 13;2(3):242–3.
Tcheng, J., et al. “Equipoise in the Enhanced Supression of the Platelet IIb/IIIa Receptor with Integrilin Trial (ESPRIT): A critical appraisal. Comment.” Clinical Trials, vol. 2, no. 3, July 2005, pp. 242–43.
Tcheng J, Mann H, London AJ, Mann J. Equipoise in the Enhanced Supression of the Platelet IIb/IIIa Receptor with Integrilin Trial (ESPRIT): A critical appraisal. Comment. Clinical Trials. 2005 Jul 13;2(3):242–243.
Published In
Clinical Trials
ISSN
1740-7745
Publication Date
July 13, 2005
Volume
2
Issue
3
Start / End Page
242 / 243
Related Subject Headings
- Statistics & Probability
- 5203 Clinical and health psychology
- 4905 Statistics
- 3202 Clinical sciences
- 1103 Clinical Sciences
- 0104 Statistics